Literature DB >> 11590835

Clinical classification of pulmonary hypertension.

A P Fishman1.   

Abstract

Pulmonary hypertension is a prevalent disease of multiple etiologies. Over the years, different attempts at nomenclature and classification, largely based on morphologic findings at autopsy, have met with limited success. Recent advances in medical and surgical treatment, and the promise of effective approaches to prevention, have prompted the development of a clinical classification designed to take advantage of the new promising interventions. This article traces the growth of understanding of the pulmonary hypertensive diseases that has enabled the development of a clinical classification oriented towards prevention and treatment.

Entities:  

Mesh:

Year:  2001        PMID: 11590835     DOI: 10.1016/s0272-5231(05)70278-1

Source DB:  PubMed          Journal:  Clin Chest Med        ISSN: 0272-5231            Impact factor:   2.878


  20 in total

Review 1.  Heart failure and pulmonary hypertension.

Authors:  Jordan T Shin; Marc J Semigran
Journal:  Heart Fail Clin       Date:  2010-04       Impact factor: 3.179

2.  Influence of pulmonary hypertension on survival in advanced lung disease.

Authors:  Don Hayes; Sylvester M Black; Joseph D Tobias; Heidi M Mansour; Bryan A Whitson
Journal:  Lung       Date:  2015-02-18       Impact factor: 2.584

Review 3.  Biomarkers in pulmonary arterial hypertension.

Authors:  Julie L Rosenthal; Miriam S Jacob
Journal:  Curr Heart Fail Rep       Date:  2014-12

Review 4.  How valid are animal models to evaluate treatments for pulmonary hypertension?

Authors:  Maria E Campian; Maxim Hardziyenka; Martin C Michel; Hanno L Tan
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2006-09       Impact factor: 3.000

Review 5.  Schistosomiasis and the pulmonary vasculature (2013 Grover Conference series).

Authors:  Brian B Graham; Rahul Kumar
Journal:  Pulm Circ       Date:  2014-09       Impact factor: 3.017

Review 6.  Treatment for pulmonary hypertension including lung transplantation.

Authors:  Kengo F Kusano
Journal:  Gen Thorac Cardiovasc Surg       Date:  2011-08-18

7.  Prevalence, Predictors, and Outcomes of Pulmonary Hypertension in CKD.

Authors:  Sankar D Navaneethan; Jason Roy; Kelvin Tao; Carolyn S Brecklin; Jing Chen; Rajat Deo; John M Flack; Akinlolu O Ojo; Theodore J Plappert; Dominic S Raj; Ghulam Saydain; James H Sondheimer; Ruchi Sood; Susan P Steigerwalt; Raymond R Townsend; Raed A Dweik; Mahboob Rahman
Journal:  J Am Soc Nephrol       Date:  2015-09-18       Impact factor: 10.121

Review 8.  The emergence of oral tadalafil as a once-daily treatment for pulmonary arterial hypertension.

Authors:  Jeremy A Falk; Kiran J Philip; Ernst R Schwarz
Journal:  Vasc Health Risk Manag       Date:  2010-05-06

9.  Presence and outcomes of kidney disease in patients with pulmonary hypertension.

Authors:  Sankar D Navaneethan; Edgard Wehbe; Gustavo A Heresi; Varun Gaur; Omar A Minai; Susana Arrigain; Joseph V Nally; Jesse D Schold; Mahboob Rahman; Raed A Dweik
Journal:  Clin J Am Soc Nephrol       Date:  2014-02-27       Impact factor: 8.237

Review 10.  WHO's in second?: A practical review of World Health Organization group 2 pulmonary hypertension.

Authors:  Sif Hansdottir; Dayna J Groskreutz; Brian K Gehlbach
Journal:  Chest       Date:  2013-08       Impact factor: 9.410

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.